These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 2640764

  • 21. Activation of metabotropic glutamate receptors in the rat nucleus accumbens increases locomotor activity in a dopamine-dependent manner.
    Kim JH, Vezina P.
    J Pharmacol Exp Ther; 1997 Nov; 283(2):962-8. PubMed ID: 9353420
    [Abstract] [Full Text] [Related]

  • 22. Automatic registration of behaviour related to dopamine and noradrenaline transmission.
    Ljungberg T, Ungerstedt U.
    Eur J Pharmacol; 1976 Mar; 36(1):181-8. PubMed ID: 177298
    [Abstract] [Full Text] [Related]

  • 23. Conformationally defined adrenergic agents. II. The effect of endo- and exo-2-aminobenzobicyclo-[2.2.2] octene, conformationally defined amphetamine analogs, on the uptake and release of central catecholamines.
    Bartholow RM, Eiden LE, Ruth JA, Grunewald GL, Siebert J, Rutledge CO.
    J Pharmacol Exp Ther; 1977 Sep; 202(3):532-43. PubMed ID: 894520
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Neurochemical and behavioural correlates of the interaction between amphetamine and delta 9-tetrahydrocannabinol in the rat.
    Lew EO, Richardson JS.
    Drug Alcohol Depend; 1981 Sep; 8(2):93-101. PubMed ID: 6274603
    [Abstract] [Full Text] [Related]

  • 29. The hyperkinetic syndrome following long-term haloperidol treatment: involvement of dopamine and noradrenaline.
    Jackson DM, Dunstan R, Perrington A.
    J Neural Transm; 1979 Sep; 44(3):175-86. PubMed ID: 571456
    [Abstract] [Full Text] [Related]

  • 30. Dopamine-beta-hydroxylase inhibitors, feeding and locomotor activity: reinstatement of feeding following central norepinephrine.
    Evans KR, Beninger RJ, Eikelboom R.
    Pharmacol Biochem Behav; 1985 Apr; 22(4):535-40. PubMed ID: 3991764
    [Abstract] [Full Text] [Related]

  • 31. Central dopaminergic and noradrenergic components of bromocryptine-induced locomotor activity in mice [proceedings].
    Dolphin AC, Jenner P, Marsden CD, Sawaya MC.
    Br J Pharmacol; 1977 Mar; 59(3):467P. PubMed ID: 576587
    [No Abstract] [Full Text] [Related]

  • 32. Modification of the L-DOPA reversal of reserpine akinesia by inhibitors of dopamine-beta-hydroxylase.
    Dolphin A, Jenner P, Marsden CD.
    Eur J Pharmacol; 1976 Jan; 35(1):135-44. PubMed ID: 1253815
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Evidence for a modulatory role of catecholamines on hypothalamic somatostatin in the rat.
    Torres I, Guaza C, Fernandez-Durango R, Borrell J, Charro AL.
    Neuroendocrinology; 1982 Jan; 35(3):159-62. PubMed ID: 6127640
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Selective noradrenaline depletion markedly alters stress responses in rats.
    Glavin GB.
    Life Sci; 1985 Aug 05; 37(5):461-5. PubMed ID: 3848611
    [Abstract] [Full Text] [Related]

  • 38. The role of norepinephrine in feeding behavior.
    Rossi J, Zolovick AJ, Davies RF, Panksepp J.
    Neurosci Biobehav Rev; 1982 Aug 05; 6(2):195-204. PubMed ID: 6285235
    [Abstract] [Full Text] [Related]

  • 39. Effects of the dopamine-beta-hydroxylase inhibitor FLA 63 on the kinetics of elimination of amphetamine in the rat.
    Jonsson J, Lewander T.
    J Pharm Pharmacol; 1974 Nov 05; 26(11):907-9. PubMed ID: 4156566
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.